Not all individuals with CLL need therapy. In spite of all recent advancements, the iwCLL nevertheless suggests watchful observation for people with asymptomatic illness.86 This recommendation is based on at the least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).D